Influenza is an infection initiated by influenza virus and is usually well-known as flu. Vaccination for influenza aids in prevention of flu and get immune from influenza virus. This vaccine is highly recommended for children aged 6 months and elder. As per the World health Organization (WHO), 2017, Influenza virus is spread mainly by droplets of the infected or respiratory secretions person. It has a yearly global attack rate of 20–30% in adults and 5–10% in children. United States Influenza Vaccines Market report is comprehensive analysis of the regional market which aims to deliver complete panorama of the market to readers. This report may help you to gain knowledge about current scenario and future outlook of United States Influenza Vaccines Market.
According to the Centres for Disease Control and Prevention 2015, flu vaccinations prevented an around 1.9 million flu illnesses, many flu-associated medical visits, and thousands of flu associated hospitalizations, representing lowering of disease burden in the U.S. The collaborative efforts of various government entities such as Department of Health and Human Services’ Biomedical Advanced Research and Development Authority (BARDA) with the private sector has led to development of enhanced influenza vaccine technologies. This in turn, has upgraded influenza pandemic preparedness across the nation. Looking at the this, market growth can be fuelled by factors such as rising incidence of pandemic events, increasing awareness, improved pandemic preparedness, government initiatives, and more.
United States Influenza Vaccines Market is highly competitive industry as it has presence of many giants of pharmaceuticals industry. The report features competitive intelligence in relevance with many key players including detailed descriptions and data associated with revenue, products offered, financial performance, recent initiatives, acquisitions, collaborations, and more. Major players operating in this market are Sanofi Pasteur, GlaxoSmithKline PLC, Seqirus UK Limited, AstraZeneca, and more.
In addition, the report United States Influenza Vaccines Market talks about few more major market elements including market size, market drivers, pricing trends, production, supply, distribution, demand, effectiveness, rapid diagnostic testing for management of influenza, payment allowances and effective dates for the 2018 – 2019 flu season, major deals in United States Influenza Vaccines Market, Promising Influenza Vaccines in Clinical Development and more.
The United States Influenza Vaccines Market report may help you develop strong business acumen in relevance with the industry and its recent developments. The report shares noteworthy data and business intelligence associated with forecast of the market performance as well which may assist teams, individuals, businesses and others to develop and enhance strong understanding of the whole United States Influenza Vaccines Market.